Mike Havrilla

About The MikeHav Market Blog provides investors with a free source of stock profiles, tools, and commentaries focused on carbon credits, the healthcare sector, exchange-traded funds (ETFs), and innovative companies across all industries. I am a pharmacist and index developer who has been investing since August 1997 and freelance writing for investors since April 2007. I am also an avid runner since 1992 and have completed 18 marathons (26.2 miles) with a personal best time of 2 hours, 54 minutes. I can be contacted via email at mikehavrx[at]yahoo[dot]com. MikeHav Market Blog: www.mikehav.blogspot.com MikeHav Market Blog RSS Feed: http://feedproxy.google.com/mikehavblog Investment Web Domain Names [PDF]: www.geocities.com/mikehavrx/websites.pdf Global Carbon Trading Index [PDF]: www.geocities.com/mikehavrx/ctindex.pdf

Website

http://mikehav.blogspot.com/

Last 50 Posts by Mike Havrilla:

• »Albertis $12.8B Bid to Lease PA Turnpike Expires with No Deal
  01 Oct 2008 in Market Commentary
  
• »Congress Working Overtime: $634B Spending Bill and Bailout Plan
  27 Sep 2008 in Market Commentary
  
• »Pfizer is a Big Pharma Buy
  24 Sep 2008 in Market Commentary
  
• »Bristol-Myers Ups Bid to $62 for ImClone
  23 Sep 2008 in Biotech & Market Commentary
  
• »Climate Exchange Rebounds on Robust Results
  20 Sep 2008 in Market Commentary
  
• »Seven New ETF Opportunities
  19 Sep 2008 in Market Commentary
  
• »Cypress Bioscience: Poised for Major Move on Pending Phase 3 Results and FDA Decision
  14 Sep 2008 in Biotech & Market Commentary
  
• »Tobacco Stocks Smoking the Overall Market
  14 Sep 2008 in Market Commentary
  
• »Autos & Airlines: Next in Line for Government Aid
  14 Sep 2008 in Market Commentary
  
• »Global AnimalBiz Index
  14 Sep 2008 in Market Commentary
  
• »A Semi-Active Scandinavian ETF Proposal
  14 Sep 2008 in Denmark & Exchange Traded Funds & Finland & Norway & Sweden
  
• »Cypress Bioscience: Poised for Major Move on Pending Phase 3 Results and FDA Decision
  13 Sep 2008 in Biotech & Market Commentary
  
• »Carbon Prices Withstand Commodity Downturn
  11 Sep 2008 in Market Commentary
  
• »A Commodity Meltdown
  11 Sep 2008 in Market Commentary
  
• »A Mystery Bidder Emerges for ImClone Systems
  10 Sep 2008 in Market Commentary
  
• »Stocks to Watch for Monday September 8
  07 Sep 2008 in Stocks to Watch
  
• »FDA Table of Potential Drug Risks – from Adverse Event Reporting System (AERS)
  06 Sep 2008 in Market Commentary
  
• »Regional Banking Companies Continue to Languish
  05 Sep 2008 in Financial
  
• »Etelos Newsletter is Back from Summer Vacation
  05 Sep 2008 in Current Market News
  
• »A New Blog at www.ETFRx.com
  01 Sep 2008 in Exchange Traded Funds
  
• »Carbon ETN Holds Steady as Oil Drifts Lower
  25 Aug 2008 in Energy Markets
  
• »Pennsylvania: At the Forefront of Domestic Energy Exploration and Production
  25 Aug 2008 in Energy Markets
  
• »Addition of CNX Gas to Global Carbon Trading Index
  25 Aug 2008 in Market Commentary
  
• »CNX Gas: A Leader in Coalbed Methane Capture and the Marcellus Shale
  25 Aug 2008 in Market Commentary
  
• »Exercise Credits: A Financial Incentive to Combat a Growing Health Epidemic
  24 Aug 2008 in Biotech
  
• »Carbon Allowance Futures Commence US Trading
  21 Aug 2008 in Biotech
  
• »Updated Global Carbon Trading Index
  20 Aug 2008 in Biotech
  
• »Etelos Presentation at Noble Financial Conference
  20 Aug 2008 in Biotech
  
• »High Volatility for Global Carbon Trading Index over the Last Five Days
  20 Aug 2008 in Biotech
  
• »EcoloCap Solutions Doubles its Reserve of Carbon Credits (CERs)
  20 Aug 2008 in Biotech
  
• »Russia ETF Trading Down On Political Concerns And Decline In Commodities
  19 Aug 2008 in Biotech
  
• »An Investment Strategy for My Global Carbon Trading Index
  19 Aug 2008 in Biotech
  
• »A Global Carbon Trading Index
  16 Aug 2008 in Biotech
  
• »A Healthcare ETF Investment Strategy To Outpace The Overall Market
  13 Aug 2008 in Biotech
  
• »FDA Calendar of Decision Dates for 2008
  13 Aug 2008 in Biotech
  
• »Carbon Prices Rebound & Diverge From Continuing Fall In Oil
  12 Aug 2008 in Market Commentary
  
• »Highly Defensive PerformIdex: A Quarterly Update
  10 Aug 2008 in Biotech
  
• »Highly Defensive PerformIdex: A Quarterly Update
  10 Aug 2008 in Biotech
  
• »A Global Transport Exchange-Traded Fund Strategy
  09 Aug 2008 in Exchange Traded Funds & Market Commentary
  
• »A Global Transport Exchange-Traded Fund Strategy
  09 Aug 2008 in Exchange Traded Funds & Market Commentary
  
• »A Global Animal Care Index
  09 Aug 2008 in Market Commentary
  
• »BioSante Pharma Announces Re-Acquisition of Elestrin
  09 Aug 2008 in Biotech & Market Commentary
  
• »US Regional Bank BEARISHares: 109-Company Market Cap-Weighted Index
  08 Aug 2008 in Biotech
  
• »US Regional Bank BEARISHares: 109-Company Market Cap-Weighted Index
  08 Aug 2008 in Biotech
  
• »EXACT Sciences Next Generation Stool-Based DNA Technology Outperforms Blood Plasma Testing
  08 Aug 2008 in Biotech & Market Commentary
  
• »Foreign Telco Services: 31 Remaining Companies
  07 Aug 2008 in Market Commentary
  
• »A Foreign Telco Services Income Index
  07 Aug 2008 in Market Commentary
  
• »Cytori Therapeutics Enters Agreement for StemSource Cell Bank Sales in Singapore
  04 Aug 2008 in Market Commentary
  
• »The New Etelos Marketplace: Now Live at www.etelos.com
  04 Aug 2008 in Market Commentary
  
• »Global Land Transport BEARISHares
  03 Aug 2008 in Market Commentary